Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2013, Article ID 238284, 9 pages
http://dx.doi.org/10.1155/2013/238284
Research Article

Meta-Analysis of Microarray Data Identifies GAS6 Expression as an Independent Predictor of Poor Survival in Ovarian Cancer

1Translational Research Group, University Hospital Zurich, 8091 Zurich, Switzerland
2Ovarian Cancer Group, Adult Cancer Program, Lowy Cancer Research Centre, Prince of Wales and School of Women’s and Children’s Health Clinical School, University of New South Wales, Sydney, NSW 2052, Australia
3Mathematics Institute for Analysis and Applications (MATHAA), EPFL, 1015 Lausanne, Switzerland
4Gynecological Research Group, University Hospital Basel, 4031 Basel, Switzerland
5Institute of Clinical Pathology, University Hospital Zurich, 8091 Zurich, Switzerland
6Department of Gynecology, University Hospital Zurich, 8091 Zurich, Switzerland

Received 18 February 2013; Revised 8 May 2013; Accepted 30 May 2013

Academic Editor: David J. Yang

Copyright © 2013 Michelle Buehler et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [15 citations]

The following is the list of published articles that have cited the current article.

  • S P Whitman, J Kohlschmidt, K Maharry, S Volinia, K Mrózek, D Nicolet, M A Caligiuri, G Marcucci, C D Bloomfield, B L Powell, T H Carter, M R Baer, J E Kolitz, I-K Park, R M Stone, S Schwind, H Becker, K H Metzeler, J H Mendler, A-K Eisfeld, and A J Carroll, “GAS6 expression identifies high-risk adult AML patients: potential implications for therapy,” Leukemia, 2013. View at Publisher · View at Google Scholar
  • Elena Tomasello, Emeline Pollet, Thien-Phong Vu Manh, Gilles Uzé, and Marc Dalod, “Harnessing Mechanistic Knowledge on Beneficial Versus Deleterious IFN-I Effects to Design Innovative Immunotherapies Targeting Cytokine Activity to Specific Cell Types,” Frontiers in Immunology, vol. 5, 2014. View at Publisher · View at Google Scholar
  • Katarzyna Marta Lisowska, Barbara Jarzab, Jolanta Kupryjańczyk, Magdalena Olbryt, Volha Dudaladava, Jolanta Pamuła-Piłat, Katarzyna Kujawa, Ewa Grzybowska, Michał Jarzab, Sebastian Student, and Iwona Krystyna Rzepecka, “Gene expression analysis in ovarian cancer - faults and hints from DNA microarray study,” Frontiers in Oncology, vol. 4, 2014. View at Publisher · View at Google Scholar
  • Tao Jiang, Guoxia Liu, Lin Wang, and Hongchen Liu, “Elevated serum gas 6 is a novel prognostic biomarker in patients with oral squamous cell carcinoma,” PLoS ONE, vol. 10, no. 7, 2015. View at Publisher · View at Google Scholar
  • Mojgan Karimi-Zarchi, Seyed Mohammad Reza Mortazavizadeh, Nasrollah Bashardust, Neda Zakerian, Mahbube Zaidabadi, Pouria Yazdian-Anari, and Soraya Teimoori, “The Clinicopathologic Characteristics and 5-year Survival Rate of Epithelial Ovarian Cancer in Yazd, Iran.,” Electronic physician, vol. 7, no. 6, pp. 1399–406, 2015. View at Publisher · View at Google Scholar
  • Haleh Yasrebi, “Comparative study of joint analysis of microarray gene expression data in survival prediction and risk assessment of breast cancer patients,” Briefings in Bioinformatics, pp. bbv092, 2015. View at Publisher · View at Google Scholar
  • Francesca Roggiani, Delia Mezzanzanica, Katia Rea, and Antonella Tomassetti, “Guidance of Signaling Activations by Cadherins and Integrins in Epithelial Ovarian Cancer Cells,” International Journal of Molecular Sciences, vol. 17, no. 9, pp. 1387, 2016. View at Publisher · View at Google Scholar
  • Laura Buttitta, Russell S. Taichman, Ann M. Decker, Jingcheng Wang, Eunsohl Lee, Kenji Yumoto, Frank C. Cackowski, Peter Carmeliet, Younghun Jung, Todd M. Morgan, Lulia A. Kana, and James Rhee, “Endogenous GAS6 and Mer receptor signaling regulate prostate cancer stem cells in bone marrow,” Oncotarget, vol. 7, no. 18, pp. 25698–25711, 2016. View at Publisher · View at Google Scholar
  • Michelle A. Tran, Joana Loeza, Thanh H. Dellinger, Carlotta A. Glackin, Cai M. Roberts, Mary C. Pitruzzello, Wei Wen, and Gil Mor, “TWIST1 drives cisplatin resistance and cell survival in an ovarian cancer model, via upregulation of GAS6, L1CAM, and Akt signalling,” Scientific Reports, vol. 6, 2016. View at Publisher · View at Google Scholar
  • Erinn B. Rankin, and Amato J. Giaccia, “The receptor tyrosine kinase AXL in cancer progression,” Cancers, vol. 8, no. 11, 2016. View at Publisher · View at Google Scholar
  • Maria C Katapodi, Valeria Viassolo, Maria Caiata-Zufferey, Christos Nikolaidis, Rosmarie Bührer-Landolt, Nicole Buerki, Rossella Graffeo, Henrik Csaba Horváth, Christian Kurzeder, Manuela Rabaglio, Michael Scharfe, Corinne Urech, Tobias E Erlanger, Nicole Probst-Hensch, Karl Heinimann, Viola Heinzelmann-Schwarz, Olivia Pagani, and Pierre O Chappuis, “Cancer Predisposition Cascade Screening for Hereditary Breast/Ovarian Cancer and Lynch Syndromes in Switzerland: Study Protocol,” JMIR Research Protocols, vol. 6, no. 9, pp. e184, 2017. View at Publisher · View at Google Scholar
  • Sassan Hafizi, and Mikaella Vouri, “TAM receptor tyrosine kinases in cancer drug resistance,” Cancer Research, vol. 77, no. 11, pp. 2775–2778, 2017. View at Publisher · View at Google Scholar
  • Guiling Wu, Zhiqiang Ma, Wei Hu, Dongjin Wang, Bing Gong, Chongxi Fan, Shuai Jiang, Tian Li, Jianyuan Gao, and Yang Yang, “Molecular insights of Gas6/TAM in cancer development and therapy,” Cell Death and Disease, vol. 8, no. 3, pp. e2700, 2017. View at Publisher · View at Google Scholar
  • Davide Alocci, Marie Ghraichy, Elena Barletta, Alessandra Gastaldello, Julien Mariethoz, and Frederique Lisacek, “Understanding the glycome: an interactive view of glycosylation from glycocompositions to glycoepitopes,” Glycobiology, 2018. View at Publisher · View at Google Scholar
  • Guiling Wu, Zhiqiang Ma, Yicheng Cheng, Wei Hu, Chao Deng, Shuai Jiang, Tian Li, Fulin Chen, and Yang Yang, “Targeting Gas6/TAM in cancer cells and tumor microenvironment,” Molecular Cancer, vol. 17, no. 1, 2018. View at Publisher · View at Google Scholar